Free Trial
→ Trump's gold order: the announcement they won't put on the front page (From Reagan Gold Group) (Ad)tc pixel
OTCMKTS:DGNOF

DIAGNOS Q4 2025 Earnings Report

DIAGNOS logo
$0.14 0.00 (-1.94%)
As of 11:34 AM Eastern
ProfileEarnings History

DIAGNOS EPS Results

Actual EPS
-$0.01
Consensus EPS
-$0.01
Beat/Miss
Missed by -$0.00
One Year Ago EPS
N/A

DIAGNOS Revenue Results

Actual Revenue
$0.01 million
Expected Revenue
$0.09 million
Beat/Miss
Missed by -$78.00 thousand
YoY Revenue Growth
N/A

DIAGNOS Announcement Details

Quarter
Q4 2025
Date
5/28/2025
Time
During Market Hours
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

DIAGNOS' next earnings date is estimated for Monday, August 24, 2026, based on past reporting schedules.

Conference Call Resources

DIAGNOS Earnings Headlines

Emerging Growth Research Releases Flash Report on DIAGNOS, Highlighting Regulatory Catalysts and Commercialization Potential for CARA AI Platform
June 5, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/05/3307455/0/en/emerging-growth-research-releases-flash-report-on-diagnos-highlighting-regulatory-catalysts-and-commercialization-potential-for-cara-ai-platform.html
DIAGNOS to Present at the Emerging Growth Conference on June 10, 2026
June 3, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/03/3306199/0/en/diagnos-to-present-at-the-emerging-growth-conference-on-june-10-2026.html
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. Elon believes what Michael Robinson calls 'Project Unlimited' could unlock $100 trillion in potential growth. One little-known company sits at the center of it all, and most investors have no idea it exists. Position yourself before this company potentially hits the front page.tc pixel
June 15 at 1:00 AM  |  Weiss Ratings (Ad)
DIAGNOS Announces Amendment to Convertible Debentures
May 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/13/3294556/0/en/diagnos-announces-amendment-to-convertible-debentures.html
DIAGNOS Provides an Update on Sales and Regulatory Activities for CARA
April 8, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/08/3270399/0/en/diagnos-provides-an-update-on-sales-and-regulatory-activities-for-cara.html
DIAGNOS Successfully Completes the Renewal of US-FDA Medical Device Establishment Registration
April 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/01/3266834/0/en/DIAGNOS-Successfully-Completes-the-Renewal-of-US-FDA-Medical-Device-Establishment-Registration.html
See More DIAGNOS Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like DIAGNOS? Sign up for Earnings360's daily newsletter to receive timely earnings updates on DIAGNOS and other key companies, straight to your email.

About DIAGNOS

DIAGNOS (OTCMKTS:DGNOF) provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.

View DIAGNOS Profile
Earnings Tools